Pradaxa (dabigatran etexilate mesylate) is a prescription drug intended to act as a blood thinner, reducing the risk of stroke and blood clots for patients suffering from atrial fibrillation (AF). This condition causes an irregular heartbeat when the heart’s two upper chambers beat out of rhythm, not allowing the heart to pump blood consistently. This can lead to pooling or clotting of the blood and more serious health issues.
The FDA approved Pradaxa (manufactured by Boehringer Ingelheim) in October 2010 as a competitor of warfarin, the longstanding treatment of AF. Pradaxa, however, did not require patients to diet or monitor blood levels. It was found to reduce the risk of ischemic stroke by 35 percent compared with warfarin.
After three months on the market, Pradaxa had already been linked to 307 adverse events, about 50 percent more than the drug it was intended to replace. In 2011, Pradaxa had been linked to 541 deaths, 2,367 reports of hemorrhage, 291 reports of kidney failure and 644 reports of stroke. Other reported complications include internal bleeding, a major or life-threatening bleeding event, gastrointestinal bleeding, rectal bleeding, cerebrovascular accidents and brain hemorrhage.
Grave Complications Of Pradaxa
Pradaxa has been linked to severe bleeding episodes in the brain, gastrointestinal tract (GI), kidney and other organs, as well as incidents of stoke and death. Currently, there is no accurate way of determining the levels of the drug in the blood to know if you are at a stable, therapeutic level or if your blood is too thin or you are at risk for clots.
Presently, the only way to reverse the effects of Pradaxa is emergency dialysis, which cannot be performed on those with an unstable condition or who are experiencing an intracranial hemorrhage. The drug can trigger life-threatening bleeding complications, including a higher risk of hemorrhagic stroke, following even a minor injury such as a fall or bump.
Pradaxa Lawyers — Leading The Way In Pradaxa Lawsuits
At Lee Murphy Law Firm, our attorneys are committed to fighting on behalf of individuals who should have been protected by drug companies from the potential danger and harm caused by the medications they trusted. We have the experience and bandwidth to face the drug companies and fight for a successful outcome.